$0.44
▼ -5.7% Today
as of Jul 23, 12:10 ET
Last 30 days
Recent Press Releases & News
VivoSim Reports First Commercial Sales in China for NAMkind Testing Services (NASDAQ:VIVS)
VivoSim Enters China Market With Initial Preclinical Testing Contracts
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
Overview
52-week range
$1.18
$5.30
0% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed Dec 31, 2025 | Dec 2025 | $-1.03 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.98 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-1.14 | — | — | — | — | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-2.28 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-1.68 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-2.74 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.40 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.46 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.46 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | — | -$1.14 |
Financials
Income statement (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-3M | $-3M | — | $-3M | $-3M | $-3M | — |
| Net income | $-3M | $-3M | $-3M | — | $-3M | $-3M | $-3M | — |
| EPS (diluted) | $-1.03 | $-0.98 | $-1.14 | — | $-2.28 | $-1.68 | $-2.74 | — |
Balance sheet (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $7M | $9M | $11M | $1M | $3M | $6M | $3M |
| Inventory | — | — | — | — | $0 | $640,000 | $408,000 | $297,000 |
| Total current assets | $6M | $8M | $10M | $12M | $2M | $5M | $7M | $4M |
| Total assets | $7M | $10M | $12M | $15M | $4M | $7M | $9M | $6M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M |
| Total equity | $4M | $7M | $10M | $10M | $364,000 | $4M | $7M | $4M |
Implied volatility — last 90 days
No IV snapshots yet for VIVS.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.